Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m

Abstract The impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m was determined. Forty‐eight unacclimatized men and women were randomly assigned to stage for 2 days at one of four altitudes (2500, 3000, 3500, or 4300 m) prior to assessment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Janet E. Staab, Stephen R. Muza, Charles S. Fulco, Sean P. Andrew, Beth A. Beidleman
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/eefb33f3057c4dea9acd624003a66031
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eefb33f3057c4dea9acd624003a66031
record_format dspace
spelling oai:doaj.org-article:eefb33f3057c4dea9acd624003a660312021-11-15T09:54:40ZImpact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m2051-817X10.14814/phy2.15063https://doaj.org/article/eefb33f3057c4dea9acd624003a660312021-11-01T00:00:00Zhttps://doi.org/10.14814/phy2.15063https://doaj.org/toc/2051-817XAbstract The impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m was determined. Forty‐eight unacclimatized men and women were randomly assigned to stage for 2 days at one of four altitudes (2500, 3000, 3500, or 4300 m) prior to assessment on the summit of Pikes Peak (4300 m) for 2 days. Volunteers slept for one night at sea level (SL), two nights at respective staging altitudes, and two nights at Pikes Peak. Each wore a pulse oximeter to measure sleep arterial oxygen saturation (sSpO2, %) and number of desaturations (DeSHr, events/hr) and a wrist motion detector to estimate sleep awakenings (Awak, awakes/hr) and sleep efficiency (Eff, %). Acute mountain sickness (AMS) was assessed using the Environmental Symptoms Questionnaire and daytime SpO2 was assessed after AMS measurements. The mean of all variables for both staging days (STG) and Pikes Peak days (PP) was calculated. The sSpO2 and daytime SpO2 decreased (p < 0.05) from SL during STG in all groups in a dose‐dependent manner. During STG, DeSHr were higher (p < 0.05), Eff was lower (p < 0.05), and AMS symptoms were higher (p < 0.05) in the 3500 and 4300 m groups compared to the 2500 and 3000 m groups while Awak did not differ (p > 0.05) between groups. At PP, the sSpO2, DeSHr, Awak, and Eff were similar among all groups but the 2500 m group had greater AMS symptoms (p < 0.05) than the other groups. Two days of staging at 2500–4300 m induced a similar degree of sleep acclimatization during subsequent ascent to 4300 m but the 2500 m group was not protected against AMS at 4300 m.Janet E. StaabStephen R. MuzaCharles S. FulcoSean P. AndrewBeth A. BeidlemanWileyarticleacclimatizationaltitudehypobaric hypoxiasleepPhysiologyQP1-981ENPhysiological Reports, Vol 9, Iss 21, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic acclimatization
altitude
hypobaric hypoxia
sleep
Physiology
QP1-981
spellingShingle acclimatization
altitude
hypobaric hypoxia
sleep
Physiology
QP1-981
Janet E. Staab
Stephen R. Muza
Charles S. Fulco
Sean P. Andrew
Beth A. Beidleman
Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
description Abstract The impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m was determined. Forty‐eight unacclimatized men and women were randomly assigned to stage for 2 days at one of four altitudes (2500, 3000, 3500, or 4300 m) prior to assessment on the summit of Pikes Peak (4300 m) for 2 days. Volunteers slept for one night at sea level (SL), two nights at respective staging altitudes, and two nights at Pikes Peak. Each wore a pulse oximeter to measure sleep arterial oxygen saturation (sSpO2, %) and number of desaturations (DeSHr, events/hr) and a wrist motion detector to estimate sleep awakenings (Awak, awakes/hr) and sleep efficiency (Eff, %). Acute mountain sickness (AMS) was assessed using the Environmental Symptoms Questionnaire and daytime SpO2 was assessed after AMS measurements. The mean of all variables for both staging days (STG) and Pikes Peak days (PP) was calculated. The sSpO2 and daytime SpO2 decreased (p < 0.05) from SL during STG in all groups in a dose‐dependent manner. During STG, DeSHr were higher (p < 0.05), Eff was lower (p < 0.05), and AMS symptoms were higher (p < 0.05) in the 3500 and 4300 m groups compared to the 2500 and 3000 m groups while Awak did not differ (p > 0.05) between groups. At PP, the sSpO2, DeSHr, Awak, and Eff were similar among all groups but the 2500 m group had greater AMS symptoms (p < 0.05) than the other groups. Two days of staging at 2500–4300 m induced a similar degree of sleep acclimatization during subsequent ascent to 4300 m but the 2500 m group was not protected against AMS at 4300 m.
format article
author Janet E. Staab
Stephen R. Muza
Charles S. Fulco
Sean P. Andrew
Beth A. Beidleman
author_facet Janet E. Staab
Stephen R. Muza
Charles S. Fulco
Sean P. Andrew
Beth A. Beidleman
author_sort Janet E. Staab
title Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
title_short Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
title_full Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
title_fullStr Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
title_full_unstemmed Impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
title_sort impact of 2 days of staging at 2500–4300 m on sleep quality and quantity following subsequent exposure to 4300 m
publisher Wiley
publishDate 2021
url https://doaj.org/article/eefb33f3057c4dea9acd624003a66031
work_keys_str_mv AT janetestaab impactof2daysofstagingat25004300monsleepqualityandquantityfollowingsubsequentexposureto4300m
AT stephenrmuza impactof2daysofstagingat25004300monsleepqualityandquantityfollowingsubsequentexposureto4300m
AT charlessfulco impactof2daysofstagingat25004300monsleepqualityandquantityfollowingsubsequentexposureto4300m
AT seanpandrew impactof2daysofstagingat25004300monsleepqualityandquantityfollowingsubsequentexposureto4300m
AT bethabeidleman impactof2daysofstagingat25004300monsleepqualityandquantityfollowingsubsequentexposureto4300m
_version_ 1718428469235286016